On the interactions between mesenchymal stem cells and regulatory T cells for immunomoculation in transplantation

被引：59

作者：

Engela, Anja U. ^{[1
]}

Baan, Carla C. ^{[1
]}

Dor, Frank J. M. F. ^{[2
]}

Weimar, Willem ^{[1
]}

Hoogduijn, Martin J. ^{[1
]}

机构：

[1] Univ Med Ctr, Erasmus MC, Dept Internal Med, Transplantat Lab, NL-3000 CA Rotterdam, Netherlands

[2] Univ Med Ctr, Erasmus MC, Dept Surg, Rotterdam, Netherlands

来源：

FRONTIERS IN IMMUNOLOGY | 2012年 / 3卷

关键词：

mesenchymal stem cell; regulatory T cell; transplantation; VERSUS-HOST-DISEASE; HUMAN ADIPOSE-TISSUE; BONE-MARROW; STROMAL CELLS; GENE-EXPRESSION; KIDNEY-TRANSPLANTATION; IMMUNE DYSREGULATION; PROSTAGLANDIN E-2; CUTTING EDGE; HUMAN HEART;

D O I：

10.3389/fimmu.2012.00126

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Experimental studies have established the use of mesenchymal stem cells (MSC) as a candidate immunosuppressive therapy. MSC exert their immunomodulatory function through the inhibition of CD4(+) and CD8(+) T cell proliferation. It is unknown whether MSC impair the immunosuppressive function of regulatory T cells (Treg). In vitro and in vivo studies suggest that MSC mediate their immunomodulatory effects through the induction of Treg. In this review we will focus on the interactions between MSC and Treg, and evaluate the consequences of these cellular interplays for prospective MSC immunotherapy in organ transplantation.

引用

页数：8

共 103 条

[1] Human mesenchymal stem cells modulate allogeneic immune cell responses [J].

Aggarwal, S ;

Pittenger, MF .

BLOOD, 2005, 105 (04) :1815-1822

[2] Helios Expression Is a Marker of T Cell Activation and Proliferation [J].

Akimova, Tatiana ;

Beier, Ulf H. ;

Wang, Liqing ;

Levine, Matthew H. ;

Hancock, Wayne W. .

PLOS ONE, 2011, 6 (08)

[3] Amniotic Fluid as a Rich Source of Mesenchymal Stromal Cells for Transplantation Therapy [J].

Antonucci, Ivana ;

Stuppia, Liborio ;

Kaneko, Yuji ;

Yu, Seongjin ;

Tajiri, Naoki ;

Bae, Eunkyung C. ;

Chheda, Sonia H. ;

Weinbren, Nathan L. ;

Borlongant, Cesar V. .

CELL TRANSPLANTATION, 2011, 20 (06) :789-795

[4] Time-Dependent Migration of Systemically Delivered Bone Marrow Mesenchymal Stem Cells to the Infarcted Heart [J].

Assis, Ana Carolina M. ;

Carvalho, Juliana L. ;

Jacoby, Bruno A. ;

Ferreira, Raphael L. B. ;

Castanheira, Paula ;

Diniz, Simone O. F. ;

Cardoso, Valbert N. ;

Goes, Alfredo M. ;

Ferreira, Anderson J. .

CELL TRANSPLANTATION, 2010, 19 (02) :219-230

[5] Defective regulatory and effector T cell functions in patients with FOXP3 mutations [J].

Bacchetta, Rosa ;

Passerini, Laura ;

Gambineri, Eleonora ;

Dai, Minyue ;

Allan, Sarah E. ;

Perroni, Lucia ;

Dagna-Bricarelli, Franca ;

Sartirana, Claudia ;

Matthes-Martins, Susanne ;

Lawitschka, Anita ;

Azzari, Chiara ;

Ziegler, Steven F. ;

Levings, Megan K. ;

Roncarolo, Maria Grazia .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06) :1713-1722

[6] Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells [J].

Baratelli, F ;

Lin, Y ;

Zhu, L ;

Yang, SC ;

Heuzé-Vourc'h, N ;

Zeng, G ;

Reckamp, K ;

Dohadwala, M ;

Sharma, S ;

Dubinett, SM .

JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1483-1490

[7] Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].

Barbash, IM ;

Chouraqui, P ;

Baron, J ;

Feinberg, MS ;

Etzion, S ;

Tessone, A ;

Miller, L ;

Guetta, E ;

Zipori, D ;

Kedes, LH ;

Kloner, RA ;

Leor, J .

CIRCULATION, 2003, 108 (07) :863-868

[8] DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells [J].

Baron, Udo ;

Floess, Stefan ;

Wieczorek, Georg ;

Baumann, Katrin ;

Gruetzkau, Andreas ;

Dong, Jun ;

Thiel, Andreas ;

Boeld, Tina J. ;

Hoffmann, Petra ;

Edinger, Matthias ;

Tuerbachova, Ivana ;

Hamann, Alf ;

Olek, Sven ;

Huehn, Jochen .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (09) :2378-2389

[9] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].

Bartholomew, A ;

Sturgeon, C ;

Siatskas, M ;

Ferrer, K ;

McIntosh, K ;

Patil, S ;

Hardy, W ;

Devine, S ;

Ucker, D ;

Deans, R ;

Moseley, A ;

Hoffman, R .

EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48

[10]

Battaglia M, 2012, METHODS MOL BIOL, V821, P279, DOI 10.1007/978-1-61779-430-8_17

← 1 2 3 4 5 6 7 8 9 10 →